Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Brain Cancer

June 29, 2018

Multidisciplinary Teamwork in Guiding Treatment Decisions and Management of Patients Undergoing Surgery or Radiation for Intracranial Tumors
Primary and metastatic brain tumors are a heterogeneous group of neoplasms with varied outcomes and management strategies. CNS tumors are associated with a range of symptoms and complications such as edema, seizures, endocrinopathy, fatigue, psychiatric disorders, and venous thromboembolism that can seriously impact patients’ quality of life. These symptoms and complications can be related to the presence or progression of the disease but also can be caused or worsened by treatment – either due to damage to healthy tissues and structures or due to the destruction of the tumor itself.  Predicting whether a particular treatment will improve a patient’s quality of life is not a trivial endeavor. Because of this marked heterogeneity and wide range of serious and debilitating symptoms and complications, clinicians need to carefully review the prognostic features and treatment options for brain tumors on an individual basis and sensitively communicate these to each patient.  It is important for clinicians to recognize that involvement of an interdisciplinary team, including neurosurgeons, radiation therapists, oncologists, neurologists, and/or neuroradiologists, is a key factor in the appropriate management of these patients.

Target Audience

This educational program is designed to meet the educational needs of physicians, nurses, pharmacists, and other healthcare professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Explain to patients the differences between resection, stereotactic radiosurgery (SRS), fractionated stereotactic radiation therapy, and whole-brain radiation therapy, in terms of treatment administration, efficacy, and potential impacts on cognitive function, symptoms, and quality of life.
  • Describe the phenomenon of brain tumor pseudoprogression and its impact on patient management.
  • List common symptoms and functional problems that can be caused by brain tumors or brain tumor treatment, and explain to patients the options for management of each of these.
Additional information

This activity is supported by educational grants from:

  • Astellas
  • AstraZeneca
  • Bayer U.S. LLC
  • Celgene Corporation
  • Clovis Oncology
  • Eisai
  • Genentech
  • Jazz Pharmaceuticals, Inc.
  • Lilly
  • Novartis
  • Taiho Oncology

This activity is supported by an independent educational grant from TESARO.

This activity is supported by an independent medical education grant from Bristol-Myers Squibb.

This educational activity is supported by a medical education grant from Exelixis, Inc.

(last updated 6/13/2018)

Course summary
Available credit: 
  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation
Course opens: 
Course expires: 
Event starts: 
06/29/2018 - 3:00pm
Event ends: 
06/29/2018 - 4:00pm

Ian Parney, MD, PhD
Mayo Clinic Cancer Center

Paul Brown, MD
Mayo Clinic Cancer Center

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NCCN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 hour of Category 1 credit for completing this activity.

National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.0 contact hour.

Case Managers
This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers. Credit approval for case managers is pending for this program.


National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: TBD

Available Credit

  • 1.00 ACPE contact hours
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC contact hours
  • 1.00 CCM clock hours
  • 1.00 Participation

Accreditation Period

Course opens: 
Course expires: 


Please login or register to take this course.

Click the Take Course button to register for this upcoming live webinar.

This webinar will be presented live one time only on Friday, June 29, 2018, from 3:00 - 4:00 PM Eastern Daylight Time (EDT) (UTC -4).  To convert the start time of this webinar for other time zones, click here.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing